The Observation of Curative Effect on Leukotriene Receptor Antagonist Combined with Inhaled Hormone in the Treatment of Moderately Severe Asthma
10.3969/j.issn.1003-4706.2018.06.013
- VernacularTitle:白三烯受体拮抗剂联合吸入用激素治疗中重度哮喘的疗效
- Author:
Hong－sheng ZHAO
1
;
Hai－feng LI
Author Information
1. 昆明市第二人民医院医学急诊科
- Keywords:
Montelukast;
Budesonide inhalation suspension;
Moderately severe asthma;
Clinical curative effect
- From:
Journal of Kunming Medical University
2018;39(6):62-65
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the clinical efficacy of Montelukast in the treatment of severe asthma. Methods A retrospective analysis was conducted in the Department of Respiratory Medicine from January 2016 to August 2017.A total of 168 patients with moderately severe asthma were randomly divided into control group and observation group. The control group was treated with leukotriene receptor antagonist Montelukast and the observation group was treated with both Montelukast and budesonide inhalation suspension. Then we compared the clinical effect, lung function and blood gas index before and after treatment between the two groups. Results Significant improvement was observed in the clinical symptoms and lung function in the two groups of patients after the treatment. Compared to the control group, a better improvement was seen in the observation group (P＜0.05) . The results of blood gas analysis were significantly different between the two groups before and after the treatment (P＜0.05) . Conclusion In the treatment of moderately severe asthma, Montelukast combined with budesonide inhalation suspension has good clinical effect and can significantly alleviate symptoms, which can be widely used clinically.
